Resources

This document is for clinicians and laboratory professionals. It gives information about referral practices for PCR positive samples when isolate serotyping is not available.

This booklet provides information about the Medical Rural Bonded Scholarship (MRBS) Scheme for participants.

Statement from BreastScreen Australia about whether breast tomosynthesis, a new type of 3D mammogram, will be used in our screening program.

Statement from BreastScreen Australia about whether breast tomosynthesis, a new type of 3D mammogram, will be used in our screening program.

The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for Middle East respiratory syndrome coronavirus.

The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for severe acute respiratory syndrome coronavirus.

The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for haemophilus influenzae type b.

Australian Government response to the House of Representatives Standing Committee on Health and Ageing report: Discussion paper on the late effects of polio/post-polio syndrome

These guidelines for Public Health Units provide nationally consistent guidance on how to respond to human immunodeficiency virus (HIV). They are part of a Series of National Guidelines (SoNGs) published by the Communicable Diseases Network Australia (CDNA).

These procedures explain how laboratories should collect and handle samples from patients with suspected viral haemorrhagic fevers.

This fact sheet provides an overview of the background of the SSBA Regulatory Scheme.

This fact sheet provides information about the SSBA Regulatory Scheme’s administering body along with relevant contact details.

This fact sheet explains the emergency disease situation provisions that enable the Minister for Health and Aged Care to suspend some or all regulatory obligations for handling SSBAs should there be an SSBA-related disease outbreak.

Find out how to correctly dispose of security sensitive biological agents (SSBAs).

This fact sheet gives an overview of domestic legislation that may have affect entities handling security sensitive biological agents (SSBAs).

Learn about security sensitive biological agents (SSBAs) that can be used both for good and for harm. This is known as ‘dual-use’. Exporting these SSBAs is monitored.

This fact sheets gives an overview of international conventions that may have implications for entities handling security sensitive biological agents (SSBAs).

This report provides advice about a national framework for continuous quality improvement in Aboriginal and Torres Strait Islander primary health care.

An evaluation from 2012 to 2014 assessed the Cape York Wellbeing Centres. It looked at whether the centres reduced alcohol and substance abuse and harm in the community. This 2014 report presents the findings.

This fact sheet outlines which entities are exempt from the Security Sensitive Biological Agents (SSBA) Regulatory Scheme.

This report presents long-term, national workforce projections for doctors to 2030. It is part of our series on Australia’s Future Health Workforce.